3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
2
Ganglioneuroblastoma
2
Sarcoma, Myeloid
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pleuropulmonary blastoma
1
PRETEXT I Hepatoblastoma
1
Neuroblastoma
1
Myeloproliferative Disorders
1
Localized Extraskeletal Ewing Sarcoma
1
Leukemia, Biphenotypic, Acute
1
Burkitt Lymphoma
1
Blast Crisis
1
Interventions
Cyclophosphamide
9
glofitamab
4
Whole-Body Irradiation
4
Rituximab
4
fludarabine phosphate
3
fludarabine
3
Mycophenolic Acid
3
Melphalan
3
Doxorubicin
3
polatuzumab vedotin
2
pirtobrutinib
2
pembrolizumab
2
obinutuzumab
2
Tacrolimus
2
Sirolimus
2
Prednisone
2
Busulfan
2
zanubrutinib
1
venetoclax
1
relmacabtagene autoleucel
1
pegfilgrastim
1
axicabtagene ciloleucel
1
Vincristine
1
Triamcinolone
1
Specimen Handling
1
Receptors, Chimeric Antigen
1
Prednisolone
1
Peripheral Blood Stem Cell Transplantation
1
Oxaliplatin
1
Methotrexate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Dendritic Cell Sarcoma, Interdigitating
×
Razoxane
×
1 year
×
Clear all
No trials found.